CTLA4 and cancer: In most cancer types, the expression of immune checkpoint receptors, such as PD-1, CTLA-4, TIM-3, Lag-3, and other inhibitory molecules in CD8+ T cells is associated with the disease prognosis and is highly predictive of efficient immunotherapy with immune checkpoint inhibitors (CPIs) [44].